The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSuperdry Regulatory News (SDRY)

Share Price Information for Superdry (SDRY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.74
Bid: 0.00
Ask: 12.94
Change: 0.00 (0.00%)
Spread: 6.28 (94.294%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 6.74
SDRY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Superdry plc: Extension and increase of secondary lending facility

28 Mar 2024 16:36

Superdry plc (SDRY) Superdry plc: Extension and increase of secondary lending facility 28-March-2024 / 16:36 GMT/BST


28 March 2024

 

Superdry PLC

(“Superdry” or the “Company”)

 

Extension and increase of secondary lending facility

 

Superdry today announces that it has agreed an extension and increase to its secondary lending facility (the “Facility”) with Hilco Capital Limited (“Hilco”) that will provide the Company with improved liquidity headroom necessary to help facilitate the implementation of its turnaround plan and cost reduction programme.

 

The existing asset backed lending facility with Bantry Bay Capital Limited (“Bantry Bay”) remains in place.

 

The Hilco Facility is to be extended by six months to 7 February 2025 and will see an additional £10m made available immediately and a further £10m available for the working capital peak between September and November, subject to the approval and implementation of cost saving measures. The interest rate is 11.5% plus the Bank of England base rate on the drawn element. It is covenant-light, with borrowing availability based upon an asset base that is consistent with the Company’s current agreements with both lending parties.

 

For further information, please contact:

 

Superdry

 

 

Matthew Lee

investor.relations@superdry.com

+44 (0) 1242 586747

 

 

 

Joint Corporate Brokers

 

 

 

 

 

Peel Hunt LLP

 

+44 (0) 2074 188900

George Sellar

 

 

Andrew Clark

 

 

 

 

 

Liberum Capital Limited

 

+44 (0) 2031 002000

John Fishley

 

 

Edward Thomas

 

 

 

 

 

Media Enquiries

 

 

Tim Danaher

superdry@brunswickgroup.com

+44 (0) 207 4045959

       

 

 

Cautionary Statement

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR").


Dissemination of a Regulatory Announcement that contains inside information in accordance with the Market Abuse Regulation (MAR), transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.
ISIN:GB00B60BD277
Category Code:MSCL
TIDM:SDRY
LEI Code:213800GAQMT2WL7BW361
OAM Categories: 3.1. Additional regulated information required to be disclosed under the laws of a Member State
Sequence No.:312686
EQS News ID:1870257
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
26th Feb 20212:00 pmRNSTotal Voting Rights
17th Feb 20212:04 pmRNSDirector/PDMR Shareholding
11th Feb 20217:00 amRNSDirectorate Change
2nd Feb 202110:02 amRNSHolding(s) in Company
29th Jan 202112:00 pmRNSTotal Voting Rights
25th Jan 20212:00 pmRNSHolding(s) in Company
19th Jan 20217:00 amRNSHalf-year Report
15th Jan 20219:10 amRNSDirector/PDMR Shareholding
31st Dec 20201:00 pmRNSTotal Voting Rights
16th Dec 20207:00 amRNSDirectorate Change
15th Dec 202012:44 pmRNSDirector/PDMR Shareholding
30th Nov 20202:00 pmRNSTotal Voting Rights
16th Nov 202011:01 amRNSDirector/PDMR Shareholding
11th Nov 20201:00 pmRNSHolding(s) in Company
5th Nov 20207:00 amRNSTrading Statement
2nd Nov 202010:00 amRNSDirector/PDMR Shareholding
2nd Nov 20207:00 amRNSStatement re Interim CFO
30th Oct 20203:00 pmRNSTotal Voting Rights
27th Oct 20203:00 pmRNSDirector/PDMR Shareholding
27th Oct 202012:07 pmRNSDirector/PDMR Shareholding
22nd Oct 20202:12 pmRNSResult of AGM
22nd Oct 20208:00 amRNSDirector/PDMR Shareholding
20th Oct 20202:53 pmRNSDirector/PDMR Shareholding
19th Oct 20209:23 amRNSDirector/PDMR Shareholding
19th Oct 20209:08 amRNSStatement re AGM resolution
16th Oct 20207:00 amRNSDirectorate Change
14th Oct 202011:00 amRNSDirector/PDMR Shareholding
7th Oct 20203:44 pmRNSHolding(s) in Company
30th Sep 20202:00 pmRNSTotal Voting Rights
29th Sep 20209:10 amRNSNotice of AGM
25th Sep 202011:35 amRNSDirector/PDMR Shareholding
25th Sep 202011:30 amRNSDirector/PDMR Shareholding
23rd Sep 202012:00 pmRNSDirector/PDMR Shareholding
23rd Sep 202011:00 amRNSBlock listing Interim Review
22nd Sep 20203:15 pmRNSDirector/PDMR Shareholding
22nd Sep 202012:00 pmRNSDirector/PDMR Shareholding
22nd Sep 202012:00 pmRNSDirector/PDMR Shareholding
21st Sep 202012:00 pmRNSHolding(s) in Company
21st Sep 20207:00 amRNSFinal Results
17th Sep 202012:26 pmRNSStatement re preliminary results
15th Sep 202010:55 amRNSDirector/PDMR Shareholding
28th Aug 20203:00 pmRNSTotal Voting Rights
25th Aug 202012:02 pmRNSPrice Monitoring Extension
14th Aug 202011:00 amRNSDirector/PDMR Shareholding
10th Aug 20207:00 amRNSStatement re : New financing facility and trading
31st Jul 202011:00 amRNSTotal Voting Rights
24th Jul 20204:41 pmRNSSecond Price Monitoring Extn
24th Jul 20204:36 pmRNSPrice Monitoring Extension
23rd Jul 20209:34 amRNSHolding(s) in Company
21st Jul 202011:38 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.